Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer

Inclusion Criteria

• •Histologically confirmed non-small cell lung cancer (NSCLC).
• •ALK-positive or ROS1-positive NSCLC in Stage IB-IIIA (according to the 8th American Joint Committee on Cancer TNM edition), as assessed by investigator.
• •Complete surgical resection of the primary NSCLC must be deemed achievable, as assessed by a MDT evaluation (which should include a thoracic surgeon, specialized in oncologic procedures).
• •ECOG Performance Status of 0-1.
• •At least one measurable lesion according to RECIST 1.1.
• •Adequate organ and marrow function.